Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course
Open Access
- 1 July 1998
- journal article
- clinical trial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 41 (7), 1173-1180
- https://doi.org/10.1002/1529-0131(199807)41:7<1173::aid-art5>3.0.co;2-a
Abstract
Objective To determine the factors associated with disease activity in patients with recent‐onset (≤5 years) systemic lupus erythematosus (SLE) who were of Hispanic, African‐American, or Caucasian ethnicity. Methods Incident and prevalent cases of SLE, as defined by the American College of Rheumatology criteria for SLE, among the 3 ethnic groups were identified in Alabama (The University of Alabama at Birmingham) and Texas (The University of Texas‐Houston Health Science Center and The University of Texas Medical Branch at Galveston). Variables from the sociodemographic, clinical, immunologic, immunogenetic, behavioral, and psychological domains were obtained using validated instruments. Disease activity was ascertained with the Systemic Lupus Activity Measure (SLAM). Stepwise domain regressions with SLAM score as the dependent variable were performed. Final ethnic‐specific and overall regression models were obtained by entering variables that were retained in the domain regressions. Results SLAM scores at study entry were higher in the African Americans (mean ± SD 12.6 ± 6.9) and Hispanics (11.0 ± 6.2) than in the Caucasians (8.5 ± 3.7) (P ≤ 0.001). The final overall regression model (R2 = 28%) for higher SLAM score included the following variables: African‐American ethnicity, lack of private health insurance, abrupt disease onset, presence of anti‐Ro antibodies, absence of HLA‐DRB1*0301, higher levels of helplessness, and abnormal illness‐related behaviors. Conclusion Socioeconomic, immunologic, immunogenetic, behavioral, and psychological variables were all predictive of disease activity early in the course of SLE, irrespective of ethnic group. However, there remain ethnic group differences in disease activity that were not explained by these factors.Keywords
This publication has 33 references indexed in Scilit:
- Assessment of systemic lupus erythematosus disease activity by medical record review compared with direct standardized evaluationArthritis & Rheumatism, 1997
- Ethnicity and access to care in systemic lupus erythematosusArthritis & Rheumatism, 1996
- Going beyond demographic characteristics in arthritis research: Reflections on process in the experience of arthritisArthritis & Rheumatism, 1996
- Translation and validation of arthritis outcome measures into spanishArthritis & Rheumatism, 1995
- HIGH MORTALITY WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN HOSPITALIZED AFRICAN BLACKSRheumatology, 1994
- Systemic Lupus Erythematosus in Greece. Clinical Features, Evolution and Outcome: a Descriptive Analysis of 292 PatientsLupus, 1993
- Comparative studies of the major histocompatibility complex in french canadian and non–french canadian caucasians with systemic lupus erythematosusArthritis & Rheumatism, 1993
- Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.Annals Of The Rheumatic Diseases, 1993
- Clinical, serologic, and immunogenetic studies in childhood‐onset systemic lupus erythematosusArthritis & Rheumatism, 1993
- Morbidity of systemic lupus erythematosus: Role of race and socioeconomic statusThe American Journal of Medicine, 1991